Goc Pharmaceuticals Private Limited
Founded in 2016 and headquartered in Kerala, India.
2016 | Ernakulam, Kerala (India) | Active
Goc Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 10 Months
About Goc Pharmaceuticals
Goc Pharmaceuticals Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 April 2016 (Eight years and ten months 21 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mathew Samuel, Angel Abraham, and Vargheese Jaimon serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999KL2016PTC045486
- Company No.
045486
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2016
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Business Services
Who are the key members and board of directors at Goc Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mathew Samuel  | Director | 08-Apr-2016 | Current |
| Angel Abraham | Director | 08-Apr-2016 | Current |
| Vargheese Jaimon | Director | 08-Apr-2016 | Current |
Financial Performance of Goc Pharmaceuticals.
Enhance accessibility to Goc Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Goc Pharmaceuticals?
Unlock access to Goc Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Athirappalli Media Network Private Limited
Mathew Samuel is a mutual person
- Western Ghats Information Research Private Limited
Mathew Samuel is a mutual person
- Desertking Electromechanical Contracting Llp
Vargheese Jaimon is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Goc Pharmaceuticals?
Unlock and access historical data on people associated with Goc Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goc Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.